A Revaux1, E Laas2, J Chopier3, I Thomassin-Naggara3, E Touboul4, M Antoine5, J Gligorov6, E Darai7. 1. Centre expert de cancérologie mammaire, hôpital Tenon, HUEP, Assistance Publique-Hôpitaux de Paris, 4, rue de la Chine, 75020 Paris, France; Université Pierre-et-Marie-Curie, Sorbonne Université, institut universitaire de cancérologie, 4, place Jussieu, 75005 Paris, France; Service de gynécologie obstétrique et médecine de la reproduction, hôpital Tenon, HUEP, Assistance Publique-Hôpitaux de Paris, 4, rue de la Chine, 75020 Paris, France. Electronic address: aurelie.revaux@tnn.aphp.fr. 2. Centre expert de cancérologie mammaire, hôpital Tenon, HUEP, Assistance Publique-Hôpitaux de Paris, 4, rue de la Chine, 75020 Paris, France; Université Pierre-et-Marie-Curie, Sorbonne Université, institut universitaire de cancérologie, 4, place Jussieu, 75005 Paris, France; Service de gynécologie obstétrique et médecine de la reproduction, hôpital Tenon, HUEP, Assistance Publique-Hôpitaux de Paris, 4, rue de la Chine, 75020 Paris, France. 3. Centre expert de cancérologie mammaire, hôpital Tenon, HUEP, Assistance Publique-Hôpitaux de Paris, 4, rue de la Chine, 75020 Paris, France; Université Pierre-et-Marie-Curie, Sorbonne Université, institut universitaire de cancérologie, 4, place Jussieu, 75005 Paris, France; Service de radiologie, hôpital Tenon, HUEP, Assistance Publique-Hôpitaux de Paris, 4, rue de la Chine, 75020 Paris, France. 4. Centre expert de cancérologie mammaire, hôpital Tenon, HUEP, Assistance Publique-Hôpitaux de Paris, 4, rue de la Chine, 75020 Paris, France; Université Pierre-et-Marie-Curie, Sorbonne Université, institut universitaire de cancérologie, 4, place Jussieu, 75005 Paris, France; Service d'oncologie radiothérapie, hôpital Tenon, HUEP, Assistance Publique-Hôpitaux de Paris, 4, rue de la Chine, 75020 Paris, France. 5. Centre expert de cancérologie mammaire, hôpital Tenon, HUEP, Assistance Publique-Hôpitaux de Paris, 4, rue de la Chine, 75020 Paris, France; Université Pierre-et-Marie-Curie, Sorbonne Université, institut universitaire de cancérologie, 4, place Jussieu, 75005 Paris, France; Service d'anatomo-pathologie, hôpital Tenon, HUEP, Assistance Publique-Hôpitaux de Paris, 4, rue de la Chine, 75020 Paris, France. 6. Centre expert de cancérologie mammaire, hôpital Tenon, HUEP, Assistance Publique-Hôpitaux de Paris, 4, rue de la Chine, 75020 Paris, France; Université Pierre-et-Marie-Curie, Sorbonne Université, institut universitaire de cancérologie, 4, place Jussieu, 75005 Paris, France; Service d'oncologie médicale, université Pierre-et-Marie-Curie, Paris 6, institut universitaire de cancérologie, hôpital Tenon, Assistance Publique-Hôpitaux de Paris, 4, rue de la Chine, 75020 Paris, France. 7. Centre expert de cancérologie mammaire, hôpital Tenon, HUEP, Assistance Publique-Hôpitaux de Paris, 4, rue de la Chine, 75020 Paris, France; Université Pierre-et-Marie-Curie, Sorbonne Université, institut universitaire de cancérologie, 4, place Jussieu, 75005 Paris, France; Service de gynécologie obstétrique et médecine de la reproduction, hôpital Tenon, HUEP, Assistance Publique-Hôpitaux de Paris, 4, rue de la Chine, 75020 Paris, France; Unité Inserm UMRS 938, hôpital Saint-Antoine, 184, rue du Faubourg-Saint-Antoine, 75571 Paris cedex 12, France. Electronic address: emile.darai@tnn.aphp.fr.
Abstract
OBJECTIVES: The National Institute of the Cancer (INCA) recently published a study over the deadlines of medical care of breast cancers. We compared our delay within the framework of our expert center with their results. PATIENTS AND METHODS: Our work is a retrospective unicentric non-interventional study. We included all the patients taken care for a breast cancer to the hospital Tenon in Paris. The criteria of inclusion were a primitive breast cancer, having accepted a care for a first cancer operated over a period of three months. We recovered 9 key deadlines to study the care of our patients. RESULTS: Sixty-six patients were included. The mean age was of 55.6 years. The deadline of access to the hospital Tenon was 8.7 ± 7.7 days for the meetings of gynecology and 4.3 ± 4 days for those of radiology. The deadline of access to the diagnosis was 31.8 ± 26 days. The deadlines of access to the meeting of multidisciplinary dialogue pre-therapeutic was 13 ± 11 days. The access to the first management time was 18.5 days for the neoadjuvant chemotherapy and 13.5 days for surgery. The deadline of access to the postoperative therapeutic proposal was on average 20 ± 8 days. The deadline of access to the postoperative radiotherapy was of 197 days in case of postoperative chemotherapy vs 47.5 days without chemotherapy. The global deadline mammography-radiotherapy was of 188 days. DISCUSSION AND CONCLUSION: The deadline of access to the diagnosis, to the postoperative therapeutic proposal and the global deadline mammography-radiotherapy with adjuvant chemotherapy or neoadjuvant were longer in our center compared with the results of the INCA. The deadlines of access to the surgery and access to the radiotherapy without postoperative chemotherapy were shorter on the other hand. The contribution of the diagnosis in one day for breast cancer is probably going to allow us to improve the deadlines of care in our structure.
OBJECTIVES: The National Institute of the Cancer (INCA) recently published a study over the deadlines of medical care of breast cancers. We compared our delay within the framework of our expert center with their results. PATIENTS AND METHODS: Our work is a retrospective unicentric non-interventional study. We included all the patients taken care for a breast cancer to the hospital Tenon in Paris. The criteria of inclusion were a primitive breast cancer, having accepted a care for a first cancer operated over a period of three months. We recovered 9 key deadlines to study the care of our patients. RESULTS: Sixty-six patients were included. The mean age was of 55.6 years. The deadline of access to the hospital Tenon was 8.7 ± 7.7 days for the meetings of gynecology and 4.3 ± 4 days for those of radiology. The deadline of access to the diagnosis was 31.8 ± 26 days. The deadlines of access to the meeting of multidisciplinary dialogue pre-therapeutic was 13 ± 11 days. The access to the first management time was 18.5 days for the neoadjuvant chemotherapy and 13.5 days for surgery. The deadline of access to the postoperative therapeutic proposal was on average 20 ± 8 days. The deadline of access to the postoperative radiotherapy was of 197 days in case of postoperative chemotherapy vs 47.5 days without chemotherapy. The global deadline mammography-radiotherapy was of 188 days. DISCUSSION AND CONCLUSION: The deadline of access to the diagnosis, to the postoperative therapeutic proposal and the global deadline mammography-radiotherapy with adjuvant chemotherapy or neoadjuvant were longer in our center compared with the results of the INCA. The deadlines of access to the surgery and access to the radiotherapy without postoperative chemotherapy were shorter on the other hand. The contribution of the diagnosis in one day for breast cancer is probably going to allow us to improve the deadlines of care in our structure.